MedTrace Logo

A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19

NCT04756830 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2021-07-09

No results posted yet for this study

Summary

This is an open-label uncontrolled study in which all participants will receive two doses of the inactivated adsorbed vaccine against COVID-19, and will be followed up for safety and immunogenicity analysis for 24 months.

Conditions

Interventions

BIOLOGICAL

Adsorbed COVID-19 (inactivated) Vaccine

Participants will receive two doses with 14-days interval of adsorbed COVID-19 (inactivated) vaccine

Sponsors & Collaborators

  • Butantan Institute

    collaborator OTHER_GOV

  • D'Or Institute for Research and Education

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-19
Primary Completion
2021-09-30
Completion
2023-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04756830 on ClinicalTrials.gov